← Open Payments lookup

LARRY PIERCE: Open Payments

NPI 1689987042 · MANHATTAN, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,452 in 62 payments from 24 companies in 2025. Trend: 2023 $490 · 2024 $889 · 2025 $1,452

Food & beverage: $1,452
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP9$387
ABBVIE INC.8$146
Alkermes, Inc.5$119
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$101
Otsuka America Pharmaceutical, Inc.4$100
Lundbeck LLC4$83
Boehringer Ingelheim Pharmaceuticals, Inc.3$59
Vanda Pharmaceuticals Inc.2$54
Takeda Pharmaceuticals U.S.A., Inc.3$54
Novo Nordisk Inc3$52

Products named: AIRSUPRA, REXULTI, ARISTADA, CAPLYTA, FARXIGA, JARDIANCE, VRAYLAR, FANAPT.

Industry payments across KS — which companies pay providers there.